Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Varsha Gandhi, PhD, on Ibrutinib

Advertisement

Advertisement




Apr
26
Today In Oncology
FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs
AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer
In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer
Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved
Potential Protective Effects of Aspirin Against Colorectal Cancer
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside